<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01782820</url>
  </required_header>
  <id_info>
    <org_study_id>dexarelax</org_study_id>
    <nct_id>NCT01782820</nct_id>
  </id_info>
  <brief_title>Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kreiskrankenhaus Dormagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kreiskrankenhaus Dormagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to compare the time course of a neuromuscular block in
      patients receiving dexamethasone 8 mg in order to reduce postoperative nausea or vomiting
      several hours before surgery with patients receiving the drug immediately before induction of
      anaesthesia and patients without a dexamethasone prophylaxis. The primary end point is the
      time from start of injection of rocuronium until recovery to a train of four ratio (TOF
      ratio) of 0.9.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the time from start of injection of rocuronium until recovery to a train of four ratio (TOF ratio) of 0.9.</measure>
    <time_frame>one hour</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Neuromuscular Block, Dexamethasone</condition>
  <condition>Neuromuscular Block, Recovery</condition>
  <arm_group>
    <arm_group_label>dexamethasone late</arm_group_label>
    <description>dexamethasone during induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no dexamethasone</arm_group_label>
    <description>no dexamethasone during measurements</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexamethasone early</arm_group_label>
    <description>dexamethasone before induction of anesthesia</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients of a primary care clinic undergoing elective gynecologic abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged 18 to 65 years,

          -  American Society of Anesthesiologists Physical Status I or II,

          -  50-90 kg body weight,

          -  undergoing elective laparoscopic gynaecological surgery in general anaesthesia
             necessitating intraoperative neuromuscular blockade.

        Exclusion Criteria:

          -  expected difficulties with endotracheal intubation (history of difficult intubation,

          -  reduced opening of the mouth (&lt; 2cm), and Mallampati Score of 4),

          -  increased risk of pulmonary aspiration (gastrooesophageal reflux, full stomach,
             intestinal obstruction),

          -  known allergies to the drugs tested,

          -  pregnancy,

          -  neuromuscular disorders,

          -  intake of drugs affecting neuromuscular blockade, such as furosemide, magnesium or
             cephalosporins,

          -  hepatic-or renal insufficiency.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kreiskrankenhaus Dormagen</name>
      <address>
        <city>Dormagen</city>
        <zip>D-51375</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2013</study_first_submitted>
  <study_first_submitted_qc>February 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2013</study_first_posted>
  <last_update_submitted>February 1, 2013</last_update_submitted>
  <last_update_submitted_qc>February 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

